I have to disagree. GNBT will own a majority of shares in NGIO. So whether the SP of NGIO skyrockets on a vaccine sooner or later, GNBT will benefit. This is the linchpin for moving forward with the many GNBT-related initiatives, including the uplist, and is of paramount importance.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links